title: Rethinking ovarian cancer: recommendations for improving outcomes.
abstract: There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to improve the outcome for women with ovarian cancer. Nine major recommendations are outlined in this Opinion article.
authors.affiliation: Ovarian Cancer Action Research Centre, Imperial College London Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
authors.forename: Sebastian
authors.initials: S
authors.lastname: Vaughan
authors.forename: Jermaine I
authors.initials: JI
authors.lastname: Coward
authors.forename: Robert C
authors.initials: RC
authors.lastname: Bast
authors.forename: Andy
authors.initials: A
authors.lastname: Berchuck
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Berek
authors.forename: James D
authors.initials: JD
authors.lastname: Brenton
authors.forename: George
authors.initials: G
authors.lastname: Coukos
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Crum
authors.forename: Ronny
authors.initials: R
authors.lastname: Drapkin
authors.forename: Dariush
authors.initials: D
authors.lastname: Etemadmoghadam
authors.forename: Michael
authors.initials: M
authors.lastname: Friedlander
authors.forename: Hani
authors.initials: H
authors.lastname: Gabra
authors.forename: Stan B
authors.initials: SB
authors.lastname: Kaye
authors.forename: Chris J
authors.initials: CJ
authors.lastname: Lord
authors.forename: Ernst
authors.initials: E
authors.lastname: Lengyel
authors.forename: Douglas A
authors.initials: DA
authors.lastname: Levine
authors.forename: Iain A
authors.initials: IA
authors.lastname: McNeish
authors.forename: Usha
authors.initials: U
authors.lastname: Menon
authors.forename: Gordon B
authors.initials: GB
authors.lastname: Mills
authors.forename: Kenneth P
authors.initials: KP
authors.lastname: Nephew
authors.forename: Amit M
authors.initials: AM
authors.lastname: Oza
authors.forename: Anil K
authors.initials: AK
authors.lastname: Sood
authors.forename: Euan A
authors.initials: EA
authors.lastname: Stronach
authors.forename: Henning
authors.initials: H
authors.lastname: Walczak
authors.forename: David D
authors.initials: DD
authors.lastname: Bowtell
authors.forename: Frances R
authors.initials: FR
authors.lastname: Balkwill
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006287:Health Planning Guidelines; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents